Software's Valuation Trough: Growth-Adjusted Multiples Signal a Pending Inflection Point
Core Thesis
Software equities are trading at extreme valuation discounts relative to history, but the sector lacks a near-term catalyst to drive a sustained re-rating. The overall software group trades at 4.7x EV/NTM Sales — 42% below the trailing 5-year average of 8.0x. FCF multiples have collapsed even more sharply to 18.0x, 55% below the 5-year average of 40.4x. P/E (non-GAAP) sits at 14.2x, 35% below 21.7x. The sell-off is broad: the median software stock is 46.6% below its 52-week high. Underperformance versus the S&P 500 (-23.2% YTD vs +4.7%) has been driven by renewed AI disruption fears following a mixed ServiceNow earnings print (NOW -6.7% in the week). The implication: while valuations are historically compelling, investors need concrete evidence of AI monetization and revenue acceleration before re-entering.
Growth-Adjusted Multiples Understate the Discount
Even after controlling for revenue growth, software multiples are remarkably cheap. The group’s EV/NTM Sales divided by 2-year sales CAGR stands at 0.35x, compared to the trailing 5-year average of 0.51x — a 31% discount. This ratio hasn’t been at these levels since the post-COVID trough in early 2023. The 10-year UST yield (see Exhibit 6) has risen, but the compression in growth-adjusted multiple far exceeds the rate sensitivity implied by historical relationships. For high-growth names (>20% CAGR), the average EV/CY27 Sales is 15.0x, versus a 5-year peak of ~34x and average of 16.6x. The market is pricing in either a permanent deceleration in growth or a structural shift in discount rates. If growth re-accelerates or AI adoption provides a tailwind, this cohort has the most upside to a mean reversion.
Divergence Across Growth Cohorts: Mid-Growth Most Compressed
The sell-off is not uniform. Medium-growth companies (15-25% CAGR) trade at 6.0x EV/NTM Sales, 29% below their 5-year average of 8.4x. Low-growth companies (<15% CAGR) trade at 2.9x, 45% below 5.2x. High-growth names at 15.3x are only 8% below their 5-year average of 16.6x. The compression is steepest in the middle cohort, where investors have punished slowing growth but may be ignoring margin expansion or cash flow improvements. Manhattan Associates (MANH +7% in the week) shows that companies delivering earnings beats can still be rewarded. The investment implication: selective exposure to mid-growth names with strong execution and improving FCF offers a better risk/reward than chasing high-growth at still-elevated multiples or deep value in low-growth.
Key Risks: AI Disruption and Earnings Uncertainty
The primary risk is that AI disruption accelerates further, rendering current business models less valuable. The NOW sell-off (-6.7%) despite a beat indicates the market is already looking for signs of AI cannibalization. A second risk: earnings estimates may continue to fall. The median software stock is down 27.9% YTD, but consensus EPS has not fully adjusted, creating potential downside. Third, the macro environment (rates, Fed tightening) could keep multiples compressed even if fundamentals improve. Until a clear catalyst — such as a major earnings beat, AI contract wins, or rate stabilization — emerges, the sector may remain range-bound.
Valuation Implications & Tactical Positioning
Current multiples already discount a severe slowdown. On a growth-adjusted basis, software is as cheap as it has been outside of outright recessions. For long-term investors, this argues for accumulating high-quality compounders — names with durable competitive advantages, positive FCF, and exposure to structural themes (e.g., MSFT, ORCL, MANH). For tactical players, the key is timing the inflection. Watch for divergences: companies reporting accelerating billings or AI-related deal flow (like SAP +5% on results) will likely re-rate first. Avoid the lowest-quality names with high short interest (ASAN 35.1%, SAIL 34.5%) until de-risking is complete. Patience is required, but the risk/reward is shifting favorably for selective buyers.
Appendix: Key Valuation Metrics (April 24, 2026)
| Metric | Current | Trailing 5-Yr Avg | % Below 5-Yr Avg |
|---|---|---|---|
| EV/NTM Sales (Overall) | 4.7x | 8.0x | -42% |
| EV/NTM FCF (Overall) | 18.0x | 40.4x | -55% |
| P/NTM EPS (Non-GAAP) | 14.2x | 21.7x | -35% |
| EV/Sales / 2-yr CAGR | 0.35x | 0.51x | -31% |
| High-Growth (>20% CAGR) | 15.3x | 16.6x | -8% |
| Mid-Growth (15-25% CAGR) | 6.0x | 8.4x | -29% |
| Low-Growth (<15% CAGR) | 2.9x | 5.2x | -45% |